P-73 Clinical prognostic factors for overall survival and time to progression in RAS-wild type metastatic colorectal cancer treated with anti-EGFR monoclonal antibodies as third or subsequent-line therapy

Abstract

Lymphocyte ratio (NLR) prior to TARE showed an inverse relationship with the overall survival time, with a tendency to significance (p¼0.094). Conclusion:In our study, biomarkers with the ability to predict the prognosis and therapeutic response to TARE, in hepatocellular carcinoma, included morphological factors, biochemical parameters and factors related to tumor dosimetry.Legal entity responsible for the study: The authors.